Similar articles

• Extrapituitary prolactin promoter polymorphism in Czech patients with systemic lupus erythematosus and rheumatoid arthritis.

  Fojtíková M, Cerná M, Cejková P, Ruzicková S, Dostál C. Fojtíková M, et al. Ann Rheum Dis. 2007 May;66(5):706-7. doi: 10.1136/ard.2006.061788. Ann Rheum Dis. 2007. PMID: 17468404 Free PMC article. No abstract available.
• Polymorphism of the prolactin extrapituitary promoter in psoriatic arthritis.

  Stolfa J, Fojtíková M, Cejková P, Cerná M, Sedová L, Dostál C. Stolfa J, et al. Rheumatol Int. 2007 Sep;27(11):1095-6. doi: 10.1007/s00296-007-0360-3. Epub 2007 Jun 13. Rheumatol Int. 2007. PMID: 17564716 No abstract available.
• Prolactin promoter polymorphism (-1149 G/T) is associated with anti-DNA antibodies in Mexican patients with systemic lupus erythematosus.

  Montoya-Díaz E, Cervera-Castillo H, Chávez-Sánchez L, Legorreta-Haquet MV, Sánchez-González L, Chávez-Rueda K, Blanco-Favela F. Montoya-Díaz E, et al. Immunol Invest. 2011;40(6):614-26. doi: 10.3109/08820139.2011.570402. Epub 2011 Apr 18. Immunol Invest. 2011. PMID: 21500962
• Pathogenic aspects of dermatomyositis, polymyositis and overlap myositis.

  Gherardi RK. Gherardi RK. Presse Med. 2011 Apr;40(4 Pt 2):e209-18. doi: 10.1016/j.lpm.2010.12.013. Epub 2011 Mar 3. Presse Med. 2011. PMID: 21376512 Review.
• [Dermatomyositis and polymyositis].

  Pellissier JF, Civatte M, Fernandez C, Bartoli C, Chetaille B, Schleinitz N, Figarella-Branger D. Pellissier JF, et al. Rev Neurol (Paris). 2002 Oct;158(10 Pt 1):934-47. Rev Neurol (Paris). 2002. PMID: 12407302 Review. French.